🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Athlone Pharmaceuticals Limited — Licensed Medicines

29 medicines held by Athlone Pharmaceuticals Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 29 products held by Athlone Pharmaceuticals Limited
MedicineActive substanceLicence holderStatus
Amikacin 250 mg/ ml Solution for injection/infusion
PA1418/012/001
 AMIKACIN SULFATE Athlone Pharmaceuticals Limited Not marketed
Amlotan 10 mg tablet
PA1418/003/002
 Amlodipine Athlone Pharmaceuticals Limited Not marketed
Amlotan 5 mg tablet
PA1418/003/001
 Amlodipine Athlone Pharmaceuticals Limited Not marketed
Anagrelide 0.5 mg Hard Capsules
PA1418/006/001
 Anagrelide Athlone Pharmaceuticals Limited Not marketed
Azactam 1 g Powder for Solution for Injection or Infusion
PA1418/021/001
 Aztreonam Athlone Pharmaceuticals Limited Marketed
Azactam 2 g Powder for Solution for Injection or Infusion
PA1418/021/002
 Aztreonam Athlone Pharmaceuticals Limited Marketed
Carbomix 50 g Granules for Oral Suspension
PA1418/007/001
 Charcoal, activated Athlone Pharmaceuticals Limited Marketed
Doxycycline 100 mg hard capsules
PA1418/010/002
 Doxycycline hyclate Athlone Pharmaceuticals Limited Marketed
Doxycycline 50 mg hard capsules
PA1418/010/001
 Doxycycline hyclate Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 125mg/5ml Oral Solution
PA1418/016/003
 Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 125mg/5ml Oral Solution BP
PA1418/015/001
 Flucloxacillin Athlone Pharmaceuticals Limited Not marketed
Flucloxacillin 250 mg Capsules
PA1418/016/001
 Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 250mg/5ml Oral Solution
PA1418/016/004
 Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Flucloxacillin 500 mg capsules
PA1418/016/002
 Flucloxacillin Athlone Pharmaceuticals Limited Marketed
Itraconazole 10mg/ml oral solution
PA1418/004/001
 Itraconazole Athlone Pharmaceuticals Limited Not marketed
Kapake 15mg/500mg Tablets
PA1418/020/001
 Paracetamol, Codeine phosphate hemihydrate Athlone Pharmaceuticals Limited Not marketed
Kapake 30 mg/500 mg Tablets
PA1418/020/002
 Paracetamol, Codeine phosphate hemihydrate Athlone Pharmaceuticals Limited Not marketed
Kopen 250mg Tablets
PA1418/014/003
 Phenoxymethylpenicillin potassium Athlone Pharmaceuticals Limited Marketed
Kopen Sugar Free 125 mg/5 ml Powder for Oral Solution
PA1418/014/001
 Phenoxymethylpenicillin Athlone Pharmaceuticals Limited Marketed
Kopen Sugar Free 250 mg/5 ml Powder for Oral Solution
PA1418/014/002
 Phenoxymethylpenicillin Athlone Pharmaceuticals Limited Marketed
Oramox 125 mg/5 ml powder for oral suspension
PA1418/013/001
 Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 250 mg hard capsules
PA1418/013/003
 Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 250 mg/5 ml powder for oral suspension
PA1418/013/002
 Amoxicillin Athlone Pharmaceuticals Limited Marketed
Oramox 500 mg hard capsules
PA1418/013/004
 Amoxicillin Athlone Pharmaceuticals Limited Marketed
Phenylephrine Hydrochloride 10 mg/ml solution for injection/infusion
PA1418/011/001
 Phenylephrine hydrochloride Athlone Pharmaceuticals Limited Marketed
Tramadol Hydrochloride/Paracetamol 37.5 mg/325 mg Film-Coated Tablets
PA1418/009/001
 Tramadol hydrochloride, Paracetamol Athlone Pharmaceuticals Limited Not marketed
Trimethoprim 10 mg/ml Oral Suspension
PA1418/005/001
 Trimethoprim Athlone Pharmaceuticals Limited Not marketed
Trimoptin Tablets 100 mg
PA1418/008/001
 Trimethoprim Athlone Pharmaceuticals Limited Marketed
Trimoptin Tablets 200 mg
PA1418/008/002
 Trimethoprim Athlone Pharmaceuticals Limited Marketed

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.